Cite

HARVARD Citation

    Peddi, V. et al. (2023). Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor–free, Belatacept Plus Everolimus–based Immunosuppression. Transplantation direct. 9 (2), pp. e1419-. [Online]. 
  
Back to record